Cargando…

Effects of statins on the inducible degrader of low-density lipoprotein receptor in familial hypercholesterolemia

The inducible degrader of low-density lipoprotein receptor (IDOL) is an E3 ubiquitin ligase involved in the post-transcriptional regulation of LDL receptor (LDLR). Statins lower plasma LDL by activating transcription of hepatic LDLR expression, and we have determined whether statins modulate IDOL ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Melody Lok-Yi, Shiu, Sammy Wing-Ming, Cheung, Ching-Lung, Yu-Hung Leung, Anskar, Tan, Kathryn Choon-Beng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254294/
https://www.ncbi.nlm.nih.gov/pubmed/35560019
http://dx.doi.org/10.1530/EC-22-0019
_version_ 1784740665415958528
author Chan, Melody Lok-Yi
Shiu, Sammy Wing-Ming
Cheung, Ching-Lung
Yu-Hung Leung, Anskar
Tan, Kathryn Choon-Beng
author_facet Chan, Melody Lok-Yi
Shiu, Sammy Wing-Ming
Cheung, Ching-Lung
Yu-Hung Leung, Anskar
Tan, Kathryn Choon-Beng
author_sort Chan, Melody Lok-Yi
collection PubMed
description The inducible degrader of low-density lipoprotein receptor (IDOL) is an E3 ubiquitin ligase involved in the post-transcriptional regulation of LDL receptor (LDLR). Statins lower plasma LDL by activating transcription of hepatic LDLR expression, and we have determined whether statins modulate IDOL expression and influence LDLR protein abundance. IDOL expression in monocytes and serum IDOL level was determined in statin-treated familial hypercholesterolemia (FH) patients and compared with control subjects. Serum IDOL level was also evaluated in a group of untreated FH patients before and after the initiation of statin. The mechanism underlying the inhibitory effect of statin on IDOL expression was investigated in vitro. In statin-treated FH patients, serum IDOL level and its expression in monocytes was reduced compared with control (P < 0.05). In contrast, untreated FH patients had higher serum levels of IDOL and proprotein convertase subtilisin/kexintype 9 (PCSK9) than control (P < 0.05), and serum IDOL level decreased after statin therapy (P < 0.05) whereas an increase was observed in PCSK9 level (P < 0.01). In vitro, atorvastatin significantly decreased IDOL abundance in a dose-dependent manner in cultured macrophages and hepatocytes with a concomitant increase in LDLR expression. The transcription of IDOL was restored by adding either an LXR agonist T0901317 or oxysterol 22(R)-hydroxycholesterol, indicating that statin inhibited IDOL expression by reducing LXR activation. The LXR-IDOL-LDLR axis can be modulated by statins in vitro and in vivo. Statins inhibit IDOL expression by reducing LXR activation and upregulate LDLR, and statins exert the opposite effect on IDOL and PCSK9.
format Online
Article
Text
id pubmed-9254294
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Bioscientifica Ltd
record_format MEDLINE/PubMed
spelling pubmed-92542942022-07-05 Effects of statins on the inducible degrader of low-density lipoprotein receptor in familial hypercholesterolemia Chan, Melody Lok-Yi Shiu, Sammy Wing-Ming Cheung, Ching-Lung Yu-Hung Leung, Anskar Tan, Kathryn Choon-Beng Endocr Connect Research The inducible degrader of low-density lipoprotein receptor (IDOL) is an E3 ubiquitin ligase involved in the post-transcriptional regulation of LDL receptor (LDLR). Statins lower plasma LDL by activating transcription of hepatic LDLR expression, and we have determined whether statins modulate IDOL expression and influence LDLR protein abundance. IDOL expression in monocytes and serum IDOL level was determined in statin-treated familial hypercholesterolemia (FH) patients and compared with control subjects. Serum IDOL level was also evaluated in a group of untreated FH patients before and after the initiation of statin. The mechanism underlying the inhibitory effect of statin on IDOL expression was investigated in vitro. In statin-treated FH patients, serum IDOL level and its expression in monocytes was reduced compared with control (P < 0.05). In contrast, untreated FH patients had higher serum levels of IDOL and proprotein convertase subtilisin/kexintype 9 (PCSK9) than control (P < 0.05), and serum IDOL level decreased after statin therapy (P < 0.05) whereas an increase was observed in PCSK9 level (P < 0.01). In vitro, atorvastatin significantly decreased IDOL abundance in a dose-dependent manner in cultured macrophages and hepatocytes with a concomitant increase in LDLR expression. The transcription of IDOL was restored by adding either an LXR agonist T0901317 or oxysterol 22(R)-hydroxycholesterol, indicating that statin inhibited IDOL expression by reducing LXR activation. The LXR-IDOL-LDLR axis can be modulated by statins in vitro and in vivo. Statins inhibit IDOL expression by reducing LXR activation and upregulate LDLR, and statins exert the opposite effect on IDOL and PCSK9. Bioscientifica Ltd 2022-05-13 /pmc/articles/PMC9254294/ /pubmed/35560019 http://dx.doi.org/10.1530/EC-22-0019 Text en © The authors https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Research
Chan, Melody Lok-Yi
Shiu, Sammy Wing-Ming
Cheung, Ching-Lung
Yu-Hung Leung, Anskar
Tan, Kathryn Choon-Beng
Effects of statins on the inducible degrader of low-density lipoprotein receptor in familial hypercholesterolemia
title Effects of statins on the inducible degrader of low-density lipoprotein receptor in familial hypercholesterolemia
title_full Effects of statins on the inducible degrader of low-density lipoprotein receptor in familial hypercholesterolemia
title_fullStr Effects of statins on the inducible degrader of low-density lipoprotein receptor in familial hypercholesterolemia
title_full_unstemmed Effects of statins on the inducible degrader of low-density lipoprotein receptor in familial hypercholesterolemia
title_short Effects of statins on the inducible degrader of low-density lipoprotein receptor in familial hypercholesterolemia
title_sort effects of statins on the inducible degrader of low-density lipoprotein receptor in familial hypercholesterolemia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254294/
https://www.ncbi.nlm.nih.gov/pubmed/35560019
http://dx.doi.org/10.1530/EC-22-0019
work_keys_str_mv AT chanmelodylokyi effectsofstatinsontheinducibledegraderoflowdensitylipoproteinreceptorinfamilialhypercholesterolemia
AT shiusammywingming effectsofstatinsontheinducibledegraderoflowdensitylipoproteinreceptorinfamilialhypercholesterolemia
AT cheungchinglung effectsofstatinsontheinducibledegraderoflowdensitylipoproteinreceptorinfamilialhypercholesterolemia
AT yuhungleunganskar effectsofstatinsontheinducibledegraderoflowdensitylipoproteinreceptorinfamilialhypercholesterolemia
AT tankathrynchoonbeng effectsofstatinsontheinducibledegraderoflowdensitylipoproteinreceptorinfamilialhypercholesterolemia